Skip to content
CheckOrphan
  • Home
  • About Us
  • Team
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • All Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Disease
  4. /
  5. Epidermolysis bullosa dystrophica- Pasini...

Epidermolysis bullosa dystrophica- Pasini type

December 31, 2014

News

  • Regeneron Announces FDA Approval of Evkeeza
  • Relief Therapeutics Announces Survey Results Identifying Preferred Ure
  • Grant awarded to consortium led by Gain Therapeutics to advance the de
  • Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA;
  • Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Of
More News

Treatment

  • Flunarizine hydrochloride
  • Everolimus
  • Eribulin mesylate
  • Dexamethasone phosphate
  • Dantrolene sodium
More Treatment

Clinical Trial

  • A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenoc
  • The Effects of Baduanjin Qigong Exercise on Ankylosing Spondylitis: A
  • Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous S
  • An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic
  • Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
More Clinical Trial

Access Program

  • Jonsson Comprehensive Cancer Center – Progressive Metastatic Cas
  • Massachusetts General Hospital – Healthy Naturally Cycling Women
  • Kite, A Gilead Company – Relapsed/Refractory Transformed Follicu
  • Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal
  • Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell L
More Access Program

Disease

  • Neonatal alloimmune thrombocytopenia
  • Ubiquitin Disorder
  • Pseudo-Zellweger syndrome
  • Pseudoxanthoma elasticum- dominant form
  • Pseudoxanthoma elasticum- recessive form
More Disease

Research

  • Diagnostic Efficacy of Digital Dermoscopy and Clinical Findings in Thi
  • Differences in Characteristics and Outcomes Between Asian and Non-Asia
  • Arthropathy, osteolysis, keloids, relapsing conjunctival pannus and gi
  • Fetal akinesia deformation sequence due to a congenital disorder of gl
  • One case of torsades de pointes with Aase’s syndrome induced by
More Research

Network

  • Cures Within Reach
  • NGLY1.org
  • The Twin to Twin Transfusion Syndrome Foundation
  • Fetal Health Foundation
  • Plus One Foundation
More Network
Free Newsletter

Tools

Subscribe to our newsletter

Email Alerts

Rss Feeds

Print this page

Follow us on:

pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2023 CheckOrphan.
    Developed by: Gonza.io logo Powered by: Cloudscale logo